SynCore Biotechnology Co (ROCO:4192) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


ROCO:4192 SynCore Biotechnology Co Ltd ROCO:4192
67 GF Score
Price NT$20.00
GF Value NT$47.67
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is SynCore Biotechnology Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

SynCore Biotechnology Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ROCO:4192 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, SynCore Biotechnology Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SynCore Biotechnology Co Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's Margin of Safety % (DCF Earnings Based) falls into.


ROCO:4192
67GF Score
SynCore Biotechnology Co Ltd ROCO:4192
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SynCore Biotechnology Co (ROCO:4192) Overvalued in 2026?

Based on GuruFocus' analysis, SynCore Biotechnology Co stock appears to be undervalued. The current stock price of NT$20.00 is trading 58% below its estimated GF Value™ of NT$47.67. GuruFocus considers SynCore Biotechnology Co to be Possible Value Trap.

Key valuation signals for ROCO:4192:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: NT$47.67 vs. price of NT$20.00 (58% below fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SynCore Biotechnology Co Business Description

Address No. 84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biotechnology company. The pipeline products of the company include SB01 and 02, SB03, SB04, SB05, and Others. It is engaged in new drug development and sales, healthy food development and sales, medicine inspection, biotechnology services, and intellectual property. It operates in a single industry, the new drug development. The company generates the majority of its revenue from medical products and healthy food.
67GF Score

Get the complete analysis for ROCO:4192

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.00
Price
NT$47.67
GF Value